BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28176652)

  • 1. Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation.
    Martin SL; Kala R; Tollefsbol TO
    Curr Cancer Drug Targets; 2018; 18(1):97-106. PubMed ID: 28176652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
    Meeran SM; Patel SN; Tollefsbol TO
    PLoS One; 2010 Jul; 5(7):e11457. PubMed ID: 20625516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
    Abbas A; Hall JA; Patterson WL; Ho E; Hsu A; Al-Mulla F; Georgel PT
    Biochem Cell Biol; 2016 Feb; 94(1):71-81. PubMed ID: 26458818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation.
    Chen H; Landen CN; Li Y; Alvarez RD; Tollefsbol TO
    Exp Cell Res; 2013 Mar; 319(5):697-706. PubMed ID: 23333498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
    Paul B; Li Y; Tollefsbol TO
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
    Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
    Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms.
    Royston KJ; Paul B; Nozell S; Rajbhandari R; Tollefsbol TO
    Exp Cell Res; 2018 Jul; 368(1):67-74. PubMed ID: 29689276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
    He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
    Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Levels of Apoptosis Are Induced in the Human Colon Cancer HT-29 Cell Line by Co-Administration of Sulforaphane and a Peptide Nucleic Acid Targeting miR-15b-5p.
    Gasparello J; Gambari L; Papi C; Rozzi A; Manicardi A; Corradini R; Gambari R; Finotti A
    Nucleic Acid Ther; 2020 Jun; 30(3):164-174. PubMed ID: 32069125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between histone deacetylase activity and vitamin D-dependent gene expressions in relation to sulforaphane in human colorectal cancer cells.
    Hossain S; Liu Z; Wood RJ
    J Sci Food Agric; 2021 Mar; 101(5):1833-1843. PubMed ID: 32964464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
    Sharma M; Tollefsbol TO
    Exp Cell Res; 2022 Jul; 416(1):113160. PubMed ID: 35447103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs.
    Okonkwo A; Mitra J; Johnson GS; Li L; Dashwood WM; Hegde ML; Yue C; Dashwood RH; Rajendran P
    Mol Nutr Food Res; 2018 Sep; 62(18):e1800228. PubMed ID: 29924908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulforaphane-cisplatin combination inhibits the stemness and metastatic potential of TNBCs via down regulation of sirtuins-mediated EMT signaling axis.
    Sinha S; Sharma S; Sharma A; Vora J; Shrivastava N
    Phytomedicine; 2021 Apr; 84():153492. PubMed ID: 33640782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulforaphane epigenetically demethylates the CpG sites of the miR-9-3 promoter and reactivates miR-9-3 expression in human lung cancer A549 cells.
    Gao L; Cheng D; Yang J; Wu R; Li W; Kong AN
    J Nutr Biochem; 2018 Jun; 56():109-115. PubMed ID: 29525530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.
    Zhang N; Zhang R; Zou K; Yu W; Guo W; Gao Y; Li J; Li M; Tai Y; Huang W; Song C; Deng W; Cui X
    Cell Death Dis; 2017 Jul; 8(7):e2961. PubMed ID: 28749462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
    Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
    Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulforaphane suppresses in vitro and in vivo lung tumorigenesis through downregulation of HDAC activity.
    Jiang LL; Zhou SJ; Zhang XM; Chen HQ; Liu W
    Biomed Pharmacother; 2016 Mar; 78():74-80. PubMed ID: 26898427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells.
    Farhana L; Dawson MI; Fontana JA
    Cancer Biol Ther; 2015; 16(1):115-24. PubMed ID: 25611699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells.
    Royston KJ; Udayakumar N; Lewis K; Tollefsbol TO
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPT6 recruits SND1 to co-activate human telomerase reverse transcriptase to promote colon cancer progression.
    Diao C; Guo P; Yang W; Sun Y; Liao Y; Yan Y; Zhao A; Cai X; Hao J; Hu S; Yu W; Chen M; Wang R; Li W; Zuo Y; Pan J; Hua C; Lu X; Fan W; Zheng Z; Deng W; Luo G; Guo W
    Mol Oncol; 2021 Apr; 15(4):1180-1202. PubMed ID: 33305480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.